Arcus Biosciences, Inc.: cashflow_financing

Value{"amount": 33000000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityArcus Biosciences, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001724521-24-000052 · Open the official SEC filing →
Retrieved: 2026-08-19T17:38:25.694721+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001724521/cashflow-financing/2023-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/e1c91c8c-ea2f-4956-a4f5-c387b16d437f

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies